ArticleDiagnostics (Basel, Switzerland)2026
Selective Inhibition of Insulin-Degrading Enzyme Eliminates Hemolysis Interference in Serum Insulin Measurements.
María Rodríguez-García, Bernardino González de la Presa, Aleix B Fabregat-Bolufer, Naira Rico, Helena Castella, Alejandro Calvera-Rayo, Marga Giménez, Felicia A Hanzu, Manuel Morales-Ruiz, Gregori Casals
Abstract read
In one paragraphArticle in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
María Rodríguez-GarcíaBiochemistry and Molecular Genetics Department, Biomedical Diagnostic Center (CDB), Hospital Clínic of Barcelona, 08036 Barcelona, Spain.
Bernardino González de la PresaBiochemistry and Molecular Genetics Department, Biomedical Diagnostic Center (CDB), Hospital Clínic of Barcelona, 08036 Barcelona, Spain.
Aleix B Fabregat-BoluferBiochemistry and Molecular Genetics Department, Biomedical Diagnostic Center (CDB), Hospital Clínic of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-4855-0306 Naira RicoBiochemistry and Molecular Genetics Department, Biomedical Diagnostic Center (CDB), Hospital Clínic of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0001-5667-0650 Helena CastellaBiochemistry and Molecular Genetics Department, Biomedical Diagnostic Center (CDB), Hospital Clínic of Barcelona, 08036 Barcelona, Spain.
Alejandro Calvera-RayoBiochemistry and Molecular Genetics Department, Biomedical Diagnostic Center (CDB), Hospital Clínic of Barcelona, 08036 Barcelona, Spain.
Marga GiménezFundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FCRB-IDIBAPS), 08036 Barcelona, Spain.
Felicia A HanzuFundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FCRB-IDIBAPS), 08036 Barcelona, Spain.
Manuel Morales-RuizBiochemistry and Molecular Genetics Department, Biomedical Diagnostic Center (CDB), Hospital Clínic of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-9074-2272 Gregori CasalsBiochemistry and Molecular Genetics Department, Biomedical Diagnostic Center (CDB), Hospital Clínic of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-3271-1371 Funding
Agencia Estatal de Investigación PID2022-138243OB-I00 funded by MICIU/AEI /10.13039/501100011033Instituto de Salud Carlos III PI24/00688
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
hemolysisinsulininsulin-degrading enzymeinterference
Identifiers
PMID42351586
PMCPMC13297676
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390